[
  {
    "ts": null,
    "headline": "GEHC Eyes icometrix Buyout to Strengthen Neurology Imaging Portfolio",
    "summary": "GE HealthCare moves to strengthen its neurology portfolio by acquiring icometrix, aiming to integrate AI-driven brain MRI solutions into its imaging platforms.",
    "url": "https://finnhub.io/api/news?id=e217718b0c49b86a0e95905c16c0cebc68bd3b9e0c9eddb2c6725c489e9d19ce",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758033240,
      "headline": "GEHC Eyes icometrix Buyout to Strengthen Neurology Imaging Portfolio",
      "id": 136773819,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GEHC",
      "source": "Yahoo",
      "summary": "GE HealthCare moves to strengthen its neurology portfolio by acquiring icometrix, aiming to integrate AI-driven brain MRI solutions into its imaging platforms.",
      "url": "https://finnhub.io/api/news?id=e217718b0c49b86a0e95905c16c0cebc68bd3b9e0c9eddb2c6725c489e9d19ce"
    }
  },
  {
    "ts": null,
    "headline": "TEM Strengthens Radiology Portfolio With Pixel's FDA Clearance",
    "summary": "Tempus AI secures FDA clearance for its updated Pixel cardiac imaging platform, boosting radiology precision and efficiency.",
    "url": "https://finnhub.io/api/news?id=6849b0bd2e981811dd13eee7a7943b037813dc4a996960177039669d767b7a44",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758028800,
      "headline": "TEM Strengthens Radiology Portfolio With Pixel's FDA Clearance",
      "id": 136773821,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GEHC",
      "source": "Yahoo",
      "summary": "Tempus AI secures FDA clearance for its updated Pixel cardiac imaging platform, boosting radiology precision and efficiency.",
      "url": "https://finnhub.io/api/news?id=6849b0bd2e981811dd13eee7a7943b037813dc4a996960177039669d767b7a44"
    }
  },
  {
    "ts": null,
    "headline": "Is it a Prudent Move to Retain MYGN Stock in Your Portfolio Now?",
    "summary": "Myriad Genetics expands oncology testing and launches new diagnostics, but inflation and rising competition weigh on its outlook.",
    "url": "https://finnhub.io/api/news?id=751a038bdf93b7bcba52c1264008cd4d21fb46e31e4ffea70bc37e751944bb51",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758028800,
      "headline": "Is it a Prudent Move to Retain MYGN Stock in Your Portfolio Now?",
      "id": 136773820,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GEHC",
      "source": "Yahoo",
      "summary": "Myriad Genetics expands oncology testing and launches new diagnostics, but inflation and rising competition weigh on its outlook.",
      "url": "https://finnhub.io/api/news?id=751a038bdf93b7bcba52c1264008cd4d21fb46e31e4ffea70bc37e751944bb51"
    }
  }
]